Rhizopus microsporus
Rhizopus microsporus is a species of fungus in the genus Rhizopus. It is known for its role in food spoilage, plant pathology, and as an opportunistic pathogen in humans. This species is also notable for its use in the production of certain fermented foods.
Taxonomy and Classification[edit]
Rhizopus microsporus belongs to the kingdom Fungi, phylum Zygomycota, class Zygomycetes, order Mucorales, and family Mucoraceae. It is closely related to other species within the genus Rhizopus, such as Rhizopus stolonifer.
Morphology[edit]
Rhizopus microsporus is characterized by its hyphae, which are typically non-septate and can grow rapidly. The sporangia are spherical and contain numerous sporangiospores. The sporangiophores are unbranched and arise from the rhizoids.
Ecology and Habitat[edit]
This fungus is commonly found in soil, decaying organic matter, and various food products. It thrives in warm and humid environments, making it a frequent contaminant in tropical and subtropical regions.
Pathogenicity[edit]
Rhizopus microsporus is an opportunistic pathogen that can cause zygomycosis in humans, particularly in immunocompromised individuals. It can also infect plants, leading to diseases such as soft rot in fruits and vegetables.
Industrial and Food Applications[edit]
In some cultures, Rhizopus microsporus is used in the production of traditional fermented foods. For example, it is involved in the fermentation process of tempeh, a popular Indonesian food made from soybeans.
Life Cycle[edit]
The life cycle of Rhizopus microsporus includes both asexual and sexual reproduction. Asexually, it reproduces through the formation of sporangia that release sporangiospores. Sexually, it forms zygospores through the fusion of specialized hyphae from compatible mating types.
Control and Prevention[edit]
Controlling the spread of Rhizopus microsporus involves maintaining proper hygiene and storage conditions, especially in food production and healthcare settings. Antifungal treatments may be necessary for infections in humans.
See Also[edit]
References[edit]
External Links[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
